Baxter Healthcare expands IV fluid manufacturing in Australia with $40M investment

The Australian government and Baxter Healthcare each invest $20 million to expand Baxter's onshore IV fluid manufacturing capacity in Old Toongabbie, Western Sydney, increasing annual production by at least 20 million units to 80 million units by 2027.

“Our investment will now cover IV demand for Australia and we will no longer be hostage to overseas supply.”healthindustryhub.com.au

• 2 sources
• healthindustryhub.com.auBaxter partners with Labor government in expanding sovereign supply of IV fluids - Health Industry HubHealth Industry HubMar 5, 2025
• baxterhealthcare.com.auBaxter Healthcare and Australian Government announce $40 million investment towards strengthening sovereign supply of IV fluids | BaxterMar 5, 2025

Summarized from public sources; check the original articles before acting on it.